NCT01412073View on ClinicalTrials.gov

Control of Blood Loss During Caesarean Section

PHASE3CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions

Complications; Cesarean Section

Interventions

DRUG

oxytocin

group I : oxytocin 5 IU bolus over 3 minutes after delivery of the baby group II : oxytocin 5 IU bolus over 3 minutes after delivery of the baby and oxytocin infusion in 500 ml 0.9% saline over 4 hours

DRUG

Misoprostol

misoprostol intrauterine 800 microgram placed intrauterine after delivery of the baby \& the placenta

Trial Locations (1)

12211

faculty of medicine , Cairo University, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT01412073 - Control of Blood Loss During Caesarean Section | Biotech Hunter | Biotech Hunter